Sun Pharmaceutical Industries Limited Press Release Nov 12 2025
Filed with NSE · · 4 pages · English
Watch Sun Pharmaceutical Industries' latest callSun Pharmaceutical Industries (NSE:SUNPHARMA) Q1 2027 Earnings Call · Replay · Jul 31Read the transcript of Sun Pharmaceutical Industries (NSE:SUNPHARMA) Q1 2027 Earnings CallSun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
- Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
- Press Release Jul 21 2025
- Sun Pharma Announces Appointment of Richard Ascroft as CEO North America
- Press Release Jun 24 2025
Later from Sun Pharmaceutical Industries
- Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
- Press Release Nov 17 2025
- FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
- Press Release Nov 26 2025
- Sun Pharmaceutical Industries Limited Press Release Dec 01 2025
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries